Skip to main content
Clinical Trials/NCT02894242
NCT02894242CompletedNot Applicable

The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Fisher and Paykel Healthcare4 sites in 1 country22 target enrollmentStarted: September 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
22
Locations
4
Primary Endpoint
Ease of use

Study Overview

Brief Summary

This investigation is designed to evaluate the performance as well as the patients overall acceptance of the mask.

Detailed Description

A minimum of 20 OSA participants who currently use a nasal pillows mask will be recruited for the trial. Participant will be on the trial for three weeks - first week will be a collection of Positive Airway Pressure (PAP) baseline data on the participant's usual mask. The participant will then use the trial mask in-home for 2 weeks. There is also an option of a two month extension if the participant wish to continue on the trial mask.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult (18+ years of age)
  • Able to give consent
  • Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
  • Prescribed PAP for OSA
  • Existing nasal pillows user

Exclusion Criteria

  • Inability to give consent
  • Patients who are in a coma or a decreased level of consciousness
  • Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
  • Commercial drivers who are investigated by New Zealand Transport Agency
  • Current diagnosis of carbon dioxide (CO2) retention
  • Pregnant or may think they are pregnant

Outcomes

Primary Outcomes

Ease of use

Time Frame: 2 weeks in home

Subjective questionnaire

Acceptability

Time Frame: 2 weeks in home

Subjective questionnaire

Secondary Outcomes

  • Objective leak data(2 weeks in home)

Investigators

Sponsor
Fisher and Paykel Healthcare
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials